representatives of nine societies and by invited experts). - Eur j Cardiovasc Prev
Rehabi. - 2007. - Vol. 14 Suppl 2. - E1-E40.
90. Griffin, B.A. Role of plasma triglycfride in the regulation of plasma low density
lipoprotein (LDL) subfractions: relative contribution of small, dence LDL to
coronary heart disease risk / B.A. Griffin // Atherosclerois. - 1994. - Vol. 106. —
P.241-253.
91. Groot, P.H. Postprandial lipoprotein metabolism in normolipidemic men with
and without coronary artery disease / P.H. Groot // Arterioscler Thromb. - 1991.
-V o l. 1 1 .- P.653-662.
92. Grundy, S.M. Definition of metabolic syndrome: report of the National Heart,
Lung, and Blood Institute/American Heart Association conference on scientific
issues related to definition / S.M. Grundy, H.B. Brewer, J.I. Cleeman, et al. //
Circulation. - 2004. - Vol. 109. - P.433-438.
93. Grundy, S.M. Chylomicron clearence in normal and hyperlipidemic man / S.M.
Grundy, H. M ok // Metabolism. - 1976. -V o l . 25. - P. 1225-1239.
94. Haffner, S.M. A preponderance of small dense LDL is associated with specific
insulin, proinsulin and the components of the insulin resistance syndrome in non
diabetic subjects / S.M. Haffner, L. Mykkanen, D. Robbins, et al. // Diabetologia.
- 1995.-V o l . 38. - P .1328-1336.
95. Halbert, J.A. Physical activity and cardiovascular risk factors: effect of advice
from an exercise specialist in Australian genegal practice / J.A. Halbert, C.A.
Silagy, P.M. Finucane, et a l . / / Med J Aust. - 2000. - Vol. 173.- P . 84-87.
96. Hamasaki, S. Cholesterol-lowering treatment is associated with improvement in
coronary vascular remodeling and endothelial function in patients with normal or
mildly diseased coronary arteries / S. Hamasaki, S.T. Higano, J.A. Suwaidi, et al.
// Atheroscler Thromb Vase Biol. - 2000. - Vol. 20. - P.737-743.
97. Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-
risk individuals: a randomized placebo-controlled trial // Lancet. - 2002. — Vol.
360. — P.7—21.
93
